Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function.

Miñones-Moyano E, Porta S, Escaramís G, Rabionet R, Iraola S, Kagerbauer B, Espinosa-Parrilla Y, Ferrer I, Estivill X, Martí E.

Hum Mol Genet. 2011 Aug 1;20(15):3067-78. doi: 10.1093/hmg/ddr210.

PMID:
21558425
2.

MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.

Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY.

Cancer Res. 2007 Sep 15;67(18):8433-8.

3.

MicroRNAs in Parkinson's disease.

Mouradian MM.

Neurobiol Dis. 2012 May;46(2):279-84. doi: 10.1016/j.nbd.2011.12.046. Review.

PMID:
22245218
4.

Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.

Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, Tokino T.

Cancer Res. 2008 Jun 1;68(11):4123-32. doi: 10.1158/0008-5472.CAN-08-0325.

5.

Inhibition of miR-34b and miR-34c enhances α-synuclein expression in Parkinson's disease.

Kabaria S, Choi DC, Chaudhuri AD, Mouradian MM, Junn E.

FEBS Lett. 2015 Jan 30;589(3):319-25. doi: 10.1016/j.febslet.2014.12.014.

6.

miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia.

Pigazzi M, Manara E, Baron E, Basso G.

Cancer Res. 2009 Mar 15;69(6):2471-8. doi: 10.1158/0008-5472.CAN-08-3404.

8.

Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death.

Bossers K, Meerhoff G, Balesar R, van Dongen JW, Kruse CG, Swaab DF, Verhaagen J.

Brain Pathol. 2009 Jan;19(1):91-107. doi: 10.1111/j.1750-3639.2008.00171.x.

PMID:
18462474
9.

Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect.

Suzuki H, Yamamoto E, Nojima M, Kai M, Yamano HO, Yoshikawa K, Kimura T, Kudo T, Harada E, Sugai T, Takamaru H, Niinuma T, Maruyama R, Yamamoto H, Tokino T, Imai K, Toyota M, Shinomura Y.

Carcinogenesis. 2010 Dec;31(12):2066-73. doi: 10.1093/carcin/bgq203.

PMID:
20924086
10.

Upregulation of a small vault RNA (svtRNA2-1a) is an early event in Parkinson disease and induces neuronal dysfunction.

Miñones-Moyano E, Friedländer MR, Pallares J, Kagerbauer B, Porta S, Escaramís G, Ferrer I, Estivill X, Martí E.

RNA Biol. 2013 Jul;10(7):1093-106. doi: 10.4161/rna.24813.

11.

Epigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanoma.

Mazar J, Khaitan D, DeBlasio D, Zhong C, Govindarajan SS, Kopanathi S, Zhang S, Ray A, Perera RJ.

PLoS One. 2011;6(9):e24922. doi: 10.1371/journal.pone.0024922.

12.

Increased striatal adenosine A2A receptor levels is an early event in Parkinson's disease-related pathology and it is potentially regulated by miR-34b.

Villar-Menéndez I, Porta S, Buira SP, Pereira-Veiga T, Díaz-Sánchez S, Albasanz JL, Ferrer I, Martín M, Barrachina M.

Neurobiol Dis. 2014 Sep;69:206-14. doi: 10.1016/j.nbd.2014.05.030.

PMID:
24892887
13.

microRNA expression profiling of nasopharyngeal carcinoma.

Li T, Chen JX, Fu XP, Yang S, Zhang Z, Chen KhH, Li Y.

Oncol Rep. 2011 May;25(5):1353-63. doi: 10.3892/or.2011.1204.

PMID:
21373758
14.

DNA hypermethylation of microRNA-34b/c has prognostic value for stage Ⅰ non-small cell lung cancer.

Wang Z, Chen Z, Gao Y, Li N, Li B, Tan F, Tan X, Lu N, Sun Y, Sun J, Sun N, He J.

Cancer Biol Ther. 2011 Mar 1;11(5):490-6. doi: 10.4161/cbt.11.5.14550.

PMID:
21383543
15.

Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease.

Alvarez-Erviti L, Seow Y, Schapira AH, Rodriguez-Oroz MC, Obeso JA, Cooper JM.

Cell Death Dis. 2013 Mar 14;4:e545. doi: 10.1038/cddis.2013.73.

16.

Global microRNA expression profiling of Caenorhabditis elegans Parkinson's disease models.

Asikainen S, Rudgalvyte M, Heikkinen L, Louhiranta K, Lakso M, Wong G, Nass R.

J Mol Neurosci. 2010 May;41(1):210-8. doi: 10.1007/s12031-009-9325-1.

PMID:
20091141
17.

Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma.

Kubo T, Toyooka S, Tsukuda K, Sakaguchi M, Fukazawa T, Soh J, Asano H, Ueno T, Muraoka T, Yamamoto H, Nasu Y, Kishimoto T, Pass HI, Matsui H, Huh NH, Miyoshi S.

Clin Cancer Res. 2011 Aug 1;17(15):4965-74. doi: 10.1158/1078-0432.CCR-10-3040.

18.

MicroRNA miR-34b/c enhances cellular radiosensitivity of malignant pleural mesothelioma cells.

Maki Y, Asano H, Toyooka S, Soh J, Kubo T, Katsui K, Ueno T, Shien K, Muraoka T, Tanaka N, Yamamoto H, Tsukuda K, Kishimoto T, Kanazawa S, Miyoshi S.

Anticancer Res. 2012 Nov;32(11):4871-5.

PMID:
23155254
19.

Pulmonary gene and microRNA expression changes in mice exposed to benzo(a)pyrene by oral gavage.

Halappanavar S, Wu D, Williams A, Kuo B, Godschalk RW, Van Schooten FJ, Yauk CL.

Toxicology. 2011 Jul 29;285(3):133-41. doi: 10.1016/j.tox.2011.04.011.

20.
Items per page

Supplemental Content

Support Center